{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:50:29Z","timestamp":1776822629938,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2511,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.virol.2006.04.043","type":"journal-article","created":{"date-parts":[[2006,7,8]],"date-time":"2006-07-08T07:20:01Z","timestamp":1152343201000},"page":"268-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses"],"prefix":"10.1016","volume":"353","author":[{"given":"Hua-Xin","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Mao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Scearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacie","family":"Vanleeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Munir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildred","family":"McAdams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenaido T.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben-Jiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Nabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice H.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bette T.","family":"Korber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2006.04.043_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"Andre","year":"1998","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2006.04.043_bib2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/0889222041725181","article-title":"An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120","volume":"20","author":"Alam","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2006.04.043_bib3","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/JVI.75.12.5526-5540.2001","article-title":"The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region","volume":"75","author":"Barnett","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/088922200750054756","article-title":"Immunization with recombinant canarypox vectors expressing membrane-anchored gp120 followed by gp160 protein boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1","volume":"16","author":"Bures","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"11","key":"10.1016\/j.virol.2006.04.043_bib5","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/JVI.76.11.5357-5368.2002","article-title":"Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization","volume":"76","author":"Chakrabarti","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib7","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1128\/JVI.79.10.6528-6531.2005","article-title":"Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1\u2013V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels","volume":"79","author":"Chohan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib8","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib9","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission","volume":"303","author":"Derdeyn","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.04.043_bib10","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1128\/JVI.77.5.3119-3130.2003","article-title":"Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system","volume":"77","author":"Dong","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib11","doi-asserted-by":"crossref","first-page":"11214","DOI":"10.1128\/JVI.79.17.11214-11224.2005","article-title":"Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope","volume":"79","author":"Doria-Rose","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Short technical reports: compacts, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Earl","year":"1997","journal-title":"BioTechniques"},{"key":"10.1016\/j.virol.2006.04.043_bib13","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.182412199","article-title":"Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques","volume":"99","author":"Fouts","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2006.04.043_bib14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/JVI.79.2.1154-1163.2005","article-title":"Antigenicity and immunogenicity of a synthetic HIV-1 group m consensus envelope glycoprotein","volume":"79","author":"Gao","year":"2005","journal-title":"J. Virol."},{"issue":"5577","key":"10.1016\/j.virol.2006.04.043_bib15","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2006.04.043_bib17","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1128\/JVI.78.5.2394-2404.2004","article-title":"The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope","volume":"78","author":"Gorny","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib18","doi-asserted-by":"crossref","unstructured":"Gorny, M.K., Williams, C., Volsky, B., Revesz, K., Wang, X.-H., Burda, S., Nyambi, P., Krachmarov, C., Pinter, A., Zolla-Pazner, S. Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B subtypes of HIV-1. (Abstract), page 23, No. 24; AIDS Vaccine 2005, Sept. 2005, Montreal, Quebec, Canada.","DOI":"10.1128\/JVI.02202-05"},{"issue":"2","key":"10.1016\/j.virol.2006.04.043_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.virol.2003.10.009","article-title":"Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses","volume":"318","author":"Gzyl","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.043_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2005.08.042","article-title":"Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates","volume":"345","author":"Haynes","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.043_bib21","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/S0264-410X(02)00213-X","article-title":"Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C","volume":"20","author":"Hewer","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virol.2006.04.043_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1568005054201517","article-title":"Application of the polyvalent approach to HIV-1 vaccine development","volume":"5","author":"Hurwitz","year":"2005","journal-title":"Current Drug Targets. Infectious Disorders"},{"issue":"1","key":"10.1016\/j.virol.2006.04.043_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.005","article-title":"Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies","volume":"331","author":"Kang","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2006.04.043_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/viro.2002.1727","article-title":"Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies","volume":"305","author":"Kim","year":"2003","journal-title":"Virology"},{"issue":"4971","key":"10.1016\/j.virol.2006.04.043_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1126\/science.2392685","article-title":"Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant","volume":"249","author":"LaRosa","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.04.043_bib26","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virol.2006.04.043_bib27","doi-asserted-by":"crossref","first-page":"13338","DOI":"10.1128\/JVI.79.21.13338-13349.2005","article-title":"Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain","volume":"79","author":"Lian","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib28","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1128\/JVI.78.10.5270-5278.2004","article-title":"Immunogenicity of constrained monoclonal antibody A32-HIV Env gp120 complexes compared to recombinant HIV-1 gp 120 envelope glycoproteins","volume":"78","author":"Liao","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2006.04.043_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/JVI.74.1.254-263.2000","article-title":"Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of non-pathogenic and pathogenic primary isolate simian\/human immunodeficiency virus strains","volume":"74","author":"Liao","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JVI.79.2.771-779.2005","article-title":"Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins","volume":"79","author":"Mascola","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib31","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.1128\/JVI.79.16.10103-10107.2005","article-title":"Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines","volume":"79","author":"Mascola","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/173.1.60","article-title":"Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term non-progressors","volume":"173","author":"Montefiori","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2006.04.043_bib33","series-title":"Current Protocols in Immunology","first-page":"12.11.1","article-title":"Evaluating neutralizing antibodies against HIV, SIV and SHI in luciferase reporter gene assays","author":"Montefiori","year":"2004"},{"key":"10.1016\/j.virol.2006.04.043_bib34","first-page":"16:15.1","author":"Moss","year":"1998"},{"issue":"5612","key":"10.1016\/j.virol.2006.04.043_bib62","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.299.5612.1515c","article-title":"Consensus and ancestral state HIV vaccines","volume":"299","author":"Nickle","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2006.04.043_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0684.2005.00120.x","article-title":"Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate","volume":"34","author":"Pal","year":"2005","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.virol.2006.04.043_bib36","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.85.6.1932","article-title":"Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides","volume":"85","author":"Palker","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.virol.2006.04.043_bib37","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.142.10.3612","article-title":"Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120T helper cell sites and B cell neutralization epitopes","volume":"142","author":"Palker","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2006.04.043_bib38","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/JVI.73.8.6271-6281.1999","article-title":"Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of \u00d74 variants","volume":"73","author":"Ping","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib39","series-title":"Current Protocols in Immunology","first-page":"12.2.5","article-title":"Isolation and quantitation of HIV in peripheral blood","author":"Poli","year":"2004"},{"key":"10.1016\/j.virol.2006.04.043_bib40","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1128\/JVI.79.16.10210-10217.2005","article-title":"Formaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses","volume":"79","author":"Poon","year":"2005","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2006.04.043_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/088922200308747","article-title":"Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120","volume":"16","author":"Rizzuto","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2006.04.043_bib42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/sj.gt.3302275","article-title":"Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies","volume":"11","author":"Rollman","year":"2004","journal-title":"Gene Therapy"},{"issue":"9","key":"10.1016\/j.virol.2006.04.043_bib43","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1073\/pnas.85.9.3198","article-title":"Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120","volume":"89","author":"Rusche","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2006.04.043_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/abio.1994.1112","article-title":"Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis","volume":"217","author":"Schagger","year":"1994","journal-title":"Anal. Biochemistry"},{"key":"10.1016\/j.virol.2006.04.043_bib45","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1128\/JVI.76.15.7760-7776.2002","article-title":"Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein","volume":"76","author":"Schulke","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/aid.1993.9.159","article-title":"Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage","volume":"9","author":"Schulz","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2006.04.043_bib47","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.79.5.2956-2963.2005","article-title":"Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys","volume":"79","author":"Seaman","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2006.04.043_bib48","first-page":"533","article-title":"Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design","volume":"3","author":"Srivastava","year":"2004","journal-title":"Expert Rev. Vaccines"},{"issue":"6","key":"10.1016\/j.virol.2006.04.043_bib49","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","article-title":"SCD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization","volume":"72","author":"Sullivan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib51","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1128\/jvi.71.6.4319-4330.1997","article-title":"Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160","volume":"71","author":"VanCott","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2006.04.043_bib52","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1128\/JVI.73.6.4640-4650.1999","article-title":"Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope","volume":"73","author":"VanCott","year":"1999","journal-title":"J. Virol."},{"issue":"6929","key":"10.1016\/j.virol.2006.04.043_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2006.04.043_bib54","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.virol.2006.04.043_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/088922203762688649","article-title":"Characterization and selection of HIV-1 subtype C isolates for use in vaccine development","volume":"19","author":"Williamson","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2006.04.043_bib56","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/jvi.67.8.4557-4565.1993","article-title":"Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions","volume":"67","author":"Wyatt","year":"1993","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2006.04.043_bib57","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1128\/jvi.69.9.5723-5733.1995","article-title":"Involvement of the V1\/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding","volume":"69","author":"Wyatt","year":"1995","journal-title":"J. Virol."},{"issue":"6686","key":"10.1016\/j.virol.2006.04.043_bib58","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/31514","article-title":"The antigenic structure of the HIV gp120 envelope glycoprotein","volume":"39","author":"Wyatt","year":"1998","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.virol.2006.04.043_bib59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/08892220260387959","article-title":"Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies","volume":"18","author":"Xiang","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"8","key":"10.1016\/j.virol.2006.04.043_bib60","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/JVI.78.8.4029-4036.2004","article-title":"Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope","volume":"78","author":"Yang","year":"2004","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2006.04.043_bib61","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1089\/aid.2004.20.1254","article-title":"The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1","volume":"20","author":"Zolla-Pazner","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206002753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682206002753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:44:43Z","timestamp":1758584683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682206002753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0042682206002753"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2006.04.043","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2006.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}